Protalix Biotherapeutics Inc (PLX) Presyo ng Stock at Balita

HomePLX • NYSEAMERICAN

Protalix Biotherapeutics Inc

$2.05

Pre-market:

$2.09

(1.95%)+0.040

Sarado: Ene 21, 9:00:34 AM GMT-5 · USD · NYSEAMERICAN · Disclaimer

StockSegurong nakalista sa USMay headquarter sa IL

Nakaraang pagsara

$2.05

Sakop ng taon

$1.32 - $3.10

Market cap

164.86M USD

Average na Volume

714.56K

P/E ratio

44.40

Dividend yield

Mga balita tungkol sa merkado

Stock Titan

27 minuto ang nakalipas

The AI decoder that could help make quantum computers reliable

VBIX

0.00%

Investor's Business Daily

1 oras ang nakalipas

Stock Market Today: Dow Drops Ahead Of Trump Speech; Netflix Falls On Earnings (Live Coverage)

PR Newswire

22 minuto ang nakalipas

Toews Bridges Tax Gap with Launch of Hedged Nasdaq-100® ETF Seeded by Innovative '351 ETF Exchange'

NDAQ

0.00%

Yahoo Finance

37 minuto ang nakalipas

Stock market today: Dow, S&P 500, Nasdaq futures slip after brutal sell-off as Trump speaks in Davos

21 minuto ang nakalipas

Reminders Of Early April?

Trump 2.0 stock market underperforms Trump 1.0

Tungkol

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia

CEO

Dror Bashan

Itinatag

1993

Headquarters

Karmiel, North District
Israel

Website

protalix.com

Mga Empleyado

213